Genomic characterization of Achromobacter species isolates from chronic and occasional lung infection in cystic fibrosis patients

被引:14
|
作者
Veschetti, Laura [1 ]
Sandri, Angela [2 ]
Patuzzo, Cristina [1 ]
Melotti, Paola [3 ]
Malerba, Giovanni [1 ]
Lleo, Maria M. [2 ]
机构
[1] Univ Verona, Dept Neurosci Biomed & Movement Sci, I-37134 Verona, Italy
[2] Univ Verona, Dept Diagnost & Publ Hlth, Microbiol Sect, I-37134 Verona, Italy
[3] Azienda Osped Univ Integrata Verona, Cyst Fibrosis Ctr, I-37126 Verona, Italy
来源
MICROBIAL GENOMICS | 2021年 / 7卷 / 07期
关键词
Achromobacter; cystic fibrosis; lung infection; bacterial evolution; comparative genomics; virulence factors; antibiotic resistance; hypermutation; HYPERMUTABLE PSEUDOMONAS-AERUGINOSA; METALLO-BETA-LACTAMASE; MOLECULAR CHARACTERIZATION; GENETIC ADAPTATION; XYLOSOXIDANS; PREVALENCE; RESISTANCE; DATABASE; STRAINS;
D O I
10.1099/mgen.0.000606
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Achromobacter species are increasingly being detected in cystic fibrosis (CF) patients, where they can establish chronic infections by adapting to the lower airway environment. To better understand the mechanisms contributing to a successful colonization by Achromobacter species, we sequenced the whole genome of 54 isolates from 26 patients with occasional and early/late chronic lung infection. We performed a phylogenetic analysis and compared virulence and resistance genes, genetic variants and mutations, and hypermutability mechanisms between chronic and occasional isolates. We identified five Achromobacter species as well as two non- affiliated genogroups (NGs). Among them were the frequently isolated Achromobacter xylosoxidans and four other species whose clinical importance is not yet clear: Achromobacter insuavis, Achromobacter dolens, Achromobacter insolitus and Achromobacter aegrifaciens. While A. insuavis and A. dolens were isolated only from chronically infected patients and A. aegrifaciens only from occasionally infected patients, the other species were found in both groups. Most of the occasional isolates lacked functional genes involved in invasiveness, chemotaxis, type 3 secretion system and anaerobic growth, whereas the great majority ( 1 year from first colonization) and 78% of late chronic ( 1 year from first colonization) isolates were classified as hypermutators. Although all A. dolens, A. insuavis and NG isolates presented two different mutS genes, these seem to have a complementary rather than compensatory function. In conclusion, our results show that Achromobacter species can exhibit different adaptive mechanisms and some of these mechanisms might be more useful than others in establishing a chronic infection in CF patients, highlighting their importance for the clinical setting and the need for further studies on the less clinically characterized Achromobacter species.
引用
下载
收藏
页数:12
相关论文
共 50 条
  • [41] Nitrous Oxide Production in Sputum from Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Lung Infection
    Kolpen, Mette
    Kuhl, Michael
    Bjarnsholt, Thomas
    Moser, Claus
    Hansen, Christine Ronne
    Liengaard, Lars
    Kharazmi, Arsalan
    Pressler, Tanja
    Hoiby, Niels
    Jensen, Peter Ostrup
    PLOS ONE, 2014, 9 (01):
  • [42] Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study
    Esposito, Alfonso
    Pompilio, Arianna
    Bettua, Clotilde
    Crocetta, Valentina
    Giacobazzi, Elisabetta
    Fiscarelli, Ersilia
    Jousson, Olivier
    Di Bonaventura, Giovanni
    FRONTIERS IN MICROBIOLOGY, 2017, 8
  • [43] CHARACTERIZATION OF PSEUDOMONAS-CEPACIA ISOLATES FROM PATIENTS WITH CYSTIC-FIBROSIS
    MCKEVITT, AI
    WOODS, DE
    JOURNAL OF CLINICAL MICROBIOLOGY, 1984, 19 (02) : 291 - 293
  • [44] Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia
    Rees, Vanessa E.
    Lucas, Deanna S. Deveson
    Lopez-Causape, Carla
    Huang, Yuling
    Kotsimbos, Tom
    Bulitta, Jurgen B.
    Rees, Murray C.
    Barugahare, Adele
    Peleg, Anton Y.
    Nation, Roger L.
    Oliver, Antonio
    Boyce, John D.
    Landersdorfer, Cornelia B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (04)
  • [45] Genotypic characterization of sequential Aspergillus fumigatus isolates from patients with cystic fibrosis
    Verweij, PE
    Meis, JFGM
    Sarfati, J
    HoogkampKorstanje, JAA
    Latge, JP
    Melchers, WJG
    JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (10) : 2595 - 2597
  • [46] Effect of respiratory Achromobacter spp. infection on pulmonary function in patients with cystic fibrosis
    Recio, R.
    Branas, P.
    Martinez, M. T.
    Chaves, F.
    Orellana, M. A.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2018, 67 (07) : 952 - 956
  • [47] Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment
    Dupont, Chloe
    Jumas-Bilak, Estelle
    Doisy, Clara
    Aujoulat, Fabien
    Chiron, Raphael
    Marchandin, Helene
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2018, 84 (23)
  • [48] The Effect of Chronic Infection With Aspergillus fumigatus on Lung Function and Hospitalization in Patients With Cystic Fibrosis
    Amin, Reshma
    Dupuis, Annie
    Aaron, Shawn D.
    Ratjen, Felix
    CHEST, 2010, 137 (01) : 171 - 176
  • [49] DECIPHERING THE SWITCH TO CHRONIC INFECTION IN CYSTIC FIBROSIS LUNG DISEASE
    O'Connor, A.
    Dennehy, R.
    McCormack, S.
    Valvano, M.
    Berisio, R.
    McClean, S.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S298 - S298
  • [50] IS CHRONIC STENOTROPHOMONAS MALTOPHILIA INFECTION ASSOCIATED WITH MORTALITY OR LUNG TRANSPLANTATION IN CYSTIC FIBROSIS PATIENTS?
    Waters, V
    Atenafu, E. G.
    Lu, A.
    Yau, Y.
    Tullis, E.
    Ratjen, F.
    PEDIATRIC PULMONOLOGY, 2012, 47 : 323 - 323